All PlansCoverageMedium impact
Identification of Microorganisms Using Nucleic Acid Probes
Blue Cross & Blue Shield of Mississippi·MS · Infectious Disease, Pathology, Internal Medicine +6 more·Medical Policy
We identified it
Jun 20, 2026
Summary
Blue Cross Blue Shield of Mississippi has updated their medical policy for nucleic acid probe testing used to identify microorganisms. This policy defines coverage criteria for various DNA/RNA-based diagnostic tests including PCR, real-time PCR, and other molecular diagnostic techniques used to detect pathogens when traditional culture methods are inadequate.
Action Required
Billing team should review current nucleic acid probe testing claims to ensure they align with the updated policy criteria. Verify that documentation supports medical necessity based on the policy's outlined scenarios: rapid diagnosis needs, difficult-to-culture organisms, or quantitative viral load monitoring. Ensure proper coding and documentation for FDA-cleared nucleic acid amplification tests (NAATs) for CNS, GI, and respiratory panels.